Advanced search
Publication Cover
Renal Failure Volume 38, 2016 - Issue 10
Submit an article Journal homepage
1,941
Views
8
CrossRef citations to date
0
Altmetric
Clinical Study

The role of serum and urinary carbohydrate antigen 19-9 in predicting renal injury associated with ureteral stone

Erfan AminiUro-Oncology Research Center, Tehran University of Medical Sciences, Tehran, Iran;
,
Farhad PishgarUro-Oncology Research Center, Tehran University of Medical Sciences, Tehran, Iran;
,
Asal HojjatPediatric Urology Research Center, Children's Hospital Medical Center, Tehran University of Medical Sciences, Tehran, Iran;
,
Mohammad SoleimaniUrology and Nephrology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
,
Majid Ali AsgariUrology and Nephrology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
&
Abdol-Mohammad KajbafzadehPediatric Urology Research Center, Children's Hospital Medical Center, Tehran University of Medical Sciences, Tehran, Iran; Correspondence[email protected]
Pages 1626-1632 | Received 12 Apr 2016, Accepted 14 Jun 2016, Published online: 18 Oct 2016

References

  • Kilis-Pstrusinska K, Szajerka U, Zwolinska D. Unspecific increase of tumor markers in a girl with nephrotic syndrome and ovarian teratoma. Renal Fail. 2013;35:654–656.
  • Atkinson BF, Ernst CS, Herlyn M, Steplewski Z, Sears HF, Koprowski H. Gastrointestinal cancer-associated antigen in immunoperoxidase assay. Cancer Res. 1982;42:4820–4823.
  • Malaguarnera G, Giordano M, Paladina I, et al. Markers of bile duct tumors. World J Gastrointest Oncol. 2011;3:49–59.
  • Ohshio G, Manabe T, Watanabe Y, et al. Comparative studies of DU-PAN-2, carcinoembryonic antigen, and CA19-9 in the serum and bile of patients with pancreatic and biliary tract diseases: Evaluation of the influence of obstructive jaundice. Am J Gastroenterol. 1990;85:1370–1376.
  • Uygur-Bayramicli O, Dabak R, Orbay E, et al. Type 2 diabetes mellitus and CA 19-9 levels. World J Gastroenterol. 2007;13:5357–5359.
  • Kodama T, Satoh H, Ishikawa H, Ohtsuka M. Serum Levels of CA19-9 in patients with nonmalignant respiratory diseases. J Clin Lab Anal. 2007;21:103–106.
  • Aybek H, Aybek Z, Sinik Z, Demir S, Sancak B, Tuncay L. Elevation of serum and urinary carbohydrate antigen 19-9 in benign hydronephrosis. Int J Urol. 2006;13:1380–1384.
  • Lopes RI, Denes FT, Bartolamei MG, et al. Serum and urinary values of CA 19-9 and TGFss1 in a rat model of partial or complete ureteral obstruction. Eur J Pediatr Surg. 2015;25:513–519.
  • Suzuki K. Elevation of serum and urinary carbohydrate antigen 19–9 in benign hydronephrosis. Int J Urol. 2007;14:668–669.
  • Suzuki K, Muraishi O, Tokue A. The correlation of serum carbohydrate antigen 19–9 with benign hydronephrosis. J Urol. 2002;167:16–20.
  • Kajbafzadeh A-M, Elmi A, Talab SS, Emami H, Esfahani SA, Saeedi P. Urinary and serum carbohydrate antigen 19–9 as a biomarker in ureteropelvic junction obstruction in children. J Urol. 2010;183:2353–2360.
  • Moak JH, Lyons MS, Lindsell CJ. Bedside renal ultrasound in the evaluation of suspected ureterolithiasis. Am J Emerg Med. 2012;30:218–221.
  • Daggulli M, Utangac MM, Dede O, et al. Potential biomarkers for the early detection of acute kidney injury after percutaneous nephrolithotripsy. Renal Fail. 2016;38:151–156.
  • Inamoto T, Itoh S, Azuma H, Katsuoka Y, Takasaki N. Giant hydronephrosis with increased carbohydrate antigen 19–9 both in serum and fluid. Hinyokika Kiyo. 2004;50:485–488.
  • Meyer A, Kausch I, Krüger S, Fetscher S, Böhle A, Jocham D. Elevation of CA 19–9 in giant hydronephrosis induced by a renal calculus. Urology. 2004;63:381–382.
  • Kutlu O, Celik O, Koksal IT, Yigit S, Danisman A. Serum carbohydrate antigen 19-9 levels in patients with unilateral hydronephrosis due to urinary lithiasis. Minerva Urol Nefrol. 2012;64:217–221.
  • Atar A, Oktar T, Kucukgergin C, et al. The roles of serum and urinary carbohydrate antigen 19–9 in the management of patients with antenatal hydronephrosis. J Pediatr Urol. 2015;11:133.e1–133.e5.
  • Ito S, Gejyo F. Elevation of serum CA19-9 levels in benign diseases. Intern Med. 1999;38:840–841.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.